Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 3.39% 30.50 30.00 31.00 30.50 29.25 29.25 639,616 16:21:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.6 -1.2 - 48

Skinbiotherapeutics Share Discussion Threads

Showing 7451 to 7474 of 8600 messages
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older
DateSubjectAuthorDiscuss
15/8/2020
19:40
I agree its not evil - but I'm not sure those in charge would :) That said, I think paying đown/off debt, holding some good dividend stocks and holding a decent cash pile in these times, is simply good common sense, in all conditions - which aligns with advice on surviving a deflationary environment. Thus, synergies exist anyway.
lovewinshatelosses
15/8/2020
19:00
Love Yes I did say deflation. And Tbh it’s needed. It’s not an evil word either as long as everything is in line. A gold hedge is sensible but the growth sector negates some of the risk. S
shrewdmole
15/8/2020
18:37
I have just seen you said deflation, not inflation. Very interesting. We will have to disagree on that point, as I do not see it happening in any meaningful way, but the next real pressure point is going to be October or certainly November, when events across the pond play out. It will be a long time yet before things settle down and the FTSE justifies it's current heady points, all IMO.
lovewinshatelosses
15/8/2020
17:24
I agree and that's also why my biggest holding now is a precious metals miner, which I have been stake building since 2017 or so. I anticipated a bad recession hitting in 2018 (shows what I know) but continued buying since and averaging down. If like me you continue to feel bullish about the gold and silver price, this feels like one way to offset the sugarstorm somewhat of money printing, among other things. Even Warren Buffet has bought into a gold miner recently, I was reading on Bloomberg. This is highly unusual for him. Pharma and some tech stocks are the other areas that are probably a good bet right now IMO as well. All that said, I am a million miles away from being a top stock picker as some of my historic buys have shown, so good luck to us all in the next 3-5 years, whatever direction we choose.
lovewinshatelosses
15/8/2020
17:16
Pj where is this information you are quoting from? Pi's do not normally have access to company share registers.Also we know Seneca recently held a large amount in Opti and according to their recent report still do so wherever your data is coming from it doesn't appear to very accurate.
riskybusiness1
15/8/2020
17:03
risky Thats a very fair comment. However, where are they? There appear to be only x2 II on the register above 0.17%. YSF and Alliance. I cannot believe for a minute any II would take less than 0.17% of OPTI (an approx. £80k investment or below)?
pj 1
15/8/2020
16:43
SBTX has the higher short term risk reward profile but it has all the hard work to come commercially whereas Opti have built a global supply network across two areas of their business.SBTX IMO will at some point spike past it's highs & fall back similar to Opti as speculation & excitement takes over. I think some need to remember this is AIM & not low risk blue chip stocks where the share price grows on a constant & stable trajectory only falling back on profit taking. Stock prices are volatile on AIM as there is a lot of uncertainty to pre revenue stage businesses.PJ Opti raised £1m early this year in a very uncertain macro environment. This would conflict with your comment that they fail to attract new investment...from the Opti RNS they quote 'delighted to have added a number of new institutional investors to the share register.' I know what you mean, however, most II's will have an investment committee that simply will not agree to invest significant amounts in a £50m company with £750k annual sales.. no matter how excellent the progress & prospects. It is unlikely to see notifiable 3%+ interest until they prove self sustainability.
riskybusiness1
15/8/2020
16:12
Good idea shrewdmole. I am not sure what the title of her comedy series is yet. All I know is Nikki Beddi and Sonya Boyce are in it too. I’ll let you know when I do.
rafboy
15/8/2020
15:21
They don’t because we made the money it’s a generational thing. We’re about to enter a massive period of austerity and imho deflation so stock picking will be even more key. Government debt is the highest since ww2 yet we’ve reduced the defence budget every year for 20 years. The uk is a brain hub with no cash basically as the IP gets bought. S
shrewdmole
15/8/2020
14:01
I love that idea shrewdmole! Mine have not shown any interest yet in this stuff, although they like looking at graphs where vertical share price rises have taken place, so maybe not likely to be shorting the market in future :) A bit younger than yours, so the business plans may have to wait!
lovewinshatelosses
15/8/2020
13:28
There needs to be more comedy on tv instead of reality idiots so I look forward to viewing. I’m an old head in a young body though I am an only fools and horses addict and porridge, dads army, are you being served. It does raise questions as much marketing for investment is aimed at middle aged men or hnwi but the younger dynamic woman is ignored despite probably being more in to the trends that drive the company sales. I will keep an eye out for the comedy. My eldest is 16 nearly and doing business at gcse so we’re about to start a tiny investment pot for her but the deal is she has to give a detailed assessment of what she wants to invest in to us and convince us a bit like dragons den. S
shrewdmole
15/8/2020
13:09
Shrewdmole, partly as they could see the Croda deal being massive in the future and something that they would both use when the products appear on the shelves. However, the skincare products also excited a lot of interest as my youngest spends a lot of time outside on some film shoots. She is just starting a new set of short comedies for sky arts and had the honour of directing David Tennant in the first episode that is already in the can.
rafboy
15/8/2020
12:20
Thanks for all the views and comments. They have to decided to put some in each company but a slightly higher percentage in SBTX. They both see SBTX as more exciting but recognise that OPTI will also do well. Thanks again.
rafboy
15/8/2020
11:14
Mad It’s balanced because there are just so many factors. Sentiment is a huge one for aim stocks and whilst there are many in here and Opti that are hnw and experienced investors this is a new sector that tbh many of us got in at the start and maybe too early, if that’s possible. That alone creates Stale bulls and disappointment. Eg 4d was doom and gloom and forced sellers and suddenly read the board and it’s so positive. The share price Movement following seres successful trial will have alerted a lot of major investors, funds and pharma companies to the highlight the first successful pharma trial of a microbiome stock. There’s much talk of the players in this sector and the IP. Let’s not forget Opti haVe the IP to isolate and identify the strains and modulate it. Sbtx have used the lysate which is great and apparently cath has loads in the pipeline. Again the fact sederma have managed to replicate that is a huge step. I guess what I’m saying is the big unknown here is just how big this sector will become. There could be an absolute gold rush by big pharma to control as much IP and strains as possible to not only create new products but protect existing sales. Nobody on here has a clue how that could pan out. It genuinely is an ethical investment that besides hopefully making us money has real tangible benefits for everyone’s health. S
shrewdmole
15/8/2020
11:08
Raf - first of all I wouldn't even follow my own advice, let alone give it to others. My view FWIW: OPTI should now follow a steady upward trend, with excellent revenue growth every 6 months. A leg up to share price each time, with drifts in between. Any significant RNS aside, would be a bonus. I am less well versed in SBTX (but do hold now). I just have a hunch that SBTX might do an OPTI and shoot up and then retrace. So a possible need to time profit taking, if that happened. But as I say, I have no evidence for that view. Good luck whatever you/ the girls decide.
m4rtinu
15/8/2020
10:38
Shrewdmole as always has nailed it - what he said, raf! :)
lovewinshatelosses
15/8/2020
10:37
Very balanced opinion as ever. I personally think SBTX will fly and endure where OPTI will not but that is my own humble opinion.
madaboutmed
15/8/2020
10:35
Mad Always good to haVe a debate albeit I’m bullish on both companies short and medium term so I don’t like it when it gets holders pitted against one another as it’s in all our interests for both companies and the sector to do well. S
shrewdmole
15/8/2020
10:31
I have some OPTI tucked away from the 90p plus days, but they do need to deliver some really good financials fairly soon I think to get back to - and justify - previous highs; if they achieve what holders were/are hoping for, multiples of that (certainly what I had in mind when I bought in, back then). SBTX have lots in play too, as we all know, and I personally think it is as much an investors share as OPTI. However, AIM has taught me to be cautious with seductive narratives - and to trade around the fringes at certain points, to further manage risk and hopefully maximise profit. As I commented on another board the other day, this is certainly an exciting space to be involved with at the moment! GLA.
lovewinshatelosses
15/8/2020
10:25
Raf I don’t think anybody here can give you a realistic answer tbh as nobody is aware of what Discussions or imminent deals soh or SA are discussing and who with. I’m very bullish on sbtx as is clear to see and SA seems very confident and so far has done everything he says. Opti though at current levels just has that feel of a rerate due as multiple retail avenues come to market. Soh comments via twitter yesterday sum it up well that their progress with the modulators is going very well and sweetbiotix could be enormous. The seres news this week is a game changer in my view. It’s put the whole sector In the spotlight so understanding the IP value is now a consideration BUT there are so many moving parts like I say nobody can guess realistically. Plus there’s individuals points of view. I’m in both but hold more sbtx, nobby is in both but holds more Opti. FWIW - my view is Opti revenues should keep growing now with the added bonus of pharma, sweetbiotix etc that could come any time. Sbtx on the other hand. Cleanbiotix has 6 globals looking at it, my money is still on p and g. Woundcare likely to be s and n. An rns with a partner of that level attracts attention. Add in the underlying rsp (most days the mm will take loads of sbtx off you) so something going on. I took some 4d profits yesterday and added 2/3rds to Opti and 1/3rd here but that’s based on me already having a lot of sbtx. Just feel short term Opti has been left behind in the recent sector boost. Either way I’m just glad to be holding stocks in this sector as the seres share reaction shows how positive this could be. S
shrewdmole
15/8/2020
10:23
opti have over six strains oh and sweetbiotix that he could have sold for 20 million years ago around 2016
manc10
15/8/2020
10:17
Simply cannot see the double coming from OPTI. I thought this was a SBTX forum. I appreciate the holding they have but think SBTX has much wider scope and potential. Very well managed and is just getting started.
madaboutmed
15/8/2020
10:14
Chr. Hansen to acquire Valio’s LGG business for €73m
manc10
15/8/2020
10:09
Was it Theranos who had IP of $1.5 BILLION ?
pj 1
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210122 04:39:57